Moderna files for full FDA approval of its COVID-19 vaccine

Moderna today asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older. So far, 124 million doses of the Moderna vaccine have been administered in the U.S. Moderna’s request for a priority review of its Biologics License Application includes data submitted on a rolling basis culled from its ongoing phase 3 clinical trial. Moderna is currently tracking about three weeks behind Pfizer, whose application for full FDA approval of its own COVID-19 vaccine was submitted May 7.
Related News Articles
Perspective
As we move into fall and winter, we know the viruses that cause respiratory disease will usually circulate more heavily in communities. Already, the Centers…
Headline
In these video snippets from an AHA Advancing Health podcast series, health care leaders and clinicians from four children's hospitals share how they worked to…
Headline
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…